Malaria vaccine trial shows lower efficacy in younger than in older infants

BMJ 2012; 345 doi: http://dx.doi.org/10.1136/bmj.e7665 (Published 13 November 2012)
Cite this as: BMJ 2012;345:e7665

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Anne Gulland
  1. 1London

A candidate malaria vaccine has produced disappointing results, showing lower efficacy in young babies than it does in older infants, the latest trial data show.

The efficacy of the vaccine RTS,S/AS01 in infants aged 6-12 weeks against clinical and severe malaria was 31% and 37%, respectively, found the study, published in the New England Journal of Medicine.1 Last year phase 1 clinical trials of the same vaccine in infants aged 5-17 months showed an efficacy rate of 56% for clinical malaria and 47% for severe malaria.2

Salim Abdulla, principal investigator in the trial, which is being conducted by a partnership between the drug firm GlaxoSmithKline, the Malaria Vaccine Initiative, and 11 African research centres, said that the study showed the …

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Article access

Article access for 1 day

Purchase this article for £20 $30 €32*

The PDF version can be downloaded as your personal record

* Prices do not include VAT

THIS WEEK'S POLL